Work

Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/ MAPK Pathway of Hepatic Stellate Cells

Year: 2020
Type: article
Abstract: . Taken together, selonsertib suppressed fibrotic response such as HSC proliferation and extracellular matrix components by blocking the ASK1/MAPK pathway. Therefore, we suggest that selonsertib may be an effective therapeutic drug for ameliorating liver fibrosis.
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: green
OpenAlex ID: W3030976082
FWCI: 3.436
Cites: 34
Cited by: 49
Related to: 9